Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for ...

This study investigated the outcomes of perioperative multidisciplinary nursing collaboration for patients who underwent laparoscopic radical prostatectomy.

The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over ...

The probability of surgical success with telesurgery for radical prostatectomy and partial nephrectomy for small renal masses was non-inferior to local robotic surgery in a small randomized trial. The ...

DURHAM, N.C., Jan. 20, 2026 /PRNewswire/ -- Levee Medical ®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the ...

The Voro Urologic Scaffold shows promise in reducing stress urinary incontinence post-prostatectomy, with improved continence rates when optimally placed. Interim results from the ARID trial revealed ...

ABSTRACT: Objective: To investigate the application effects of the Robocare nursing model in the whole-process care of domestic robot-assisted radical prostatectomy. Methods: A total of 60 patients ...

ABSTRACT: Objective: To investigate the application effects of the Robocare nursing model in the whole-process care of domestic robot-assisted radical prostatectomy. Methods: A total of 60 patients ...